Newcastle Disease Virus Vaccine Encapsulated in Biodegradable Nanoparticles for Mucosal Delivery of a Human Vaccine

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2014 Nov 27

PMID 25424963

Citations 2

Authors

Yanwei Sun

Yang Zhang

Ci Shi

Wei Li

Gang Chen

Xiaohua Wang

Kai Zhao

Affiliations

Soon will be listed here.

Abstract

An overwhelming number of medicines on the market are oral medicine with the disadvantage of lower bioavailability universally. Newcastle disease (ND) has become a serious disease that threatens the poultry industries in many countries, and there are no treatments available for ND. The biodegradable materials could be surface modified and protect antigen or DNA from damage. Furthermore, nanoparticles are also a potential drug delivery with proper size. However, Newcastle disease virus (NDV) vaccines encapsulated in nanoparticles were widely used due to their proved a high safety and induced quicker and better mucosal and humoral immune responses. Here we review the results of mucosal immune delivery system for ND. Due to the safety, low toxicity, and better immunogenicity of the mucosal immune delivery system, our studies provide a clearly view that used the biodegradable materials to research and develop the human vaccines to save more patients' lives. These promising results provide a foundation for testing the approach in humans.

Citing Articles

Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19.

Saravanan M, Mostafavi E, Vincent S, Negash H, Andavar R, Perumal V Microb Pathog. 2021; 156:104908.

PMID: 33932543 PMC: 8079947. DOI: 10.1016/j.micpath.2021.104908.

CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells.

Zhu R, Zhang C, Liu Y, Yuan Z, Chen W, Yang S Sci Rep. 2015; 5:17904.

PMID: 26639052 PMC: 4671144. DOI: 10.1038/srep17904.

References

Loke C, Omar A, Raha A, Yusoff K . Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet Immunol Immunopathol. 2005; 106(3-4):259-67. DOI: 10.1016/j.vetimm.2005.03.005. View

Basarkar A, Devineni D, Palaniappan R, Singh J . Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm. 2007; 343(1-2):247-54. PMC: 6186392. DOI: 10.1016/j.ijpharm.2007.05.023. View

Gunbeyaz M, Faraji A, Ozkul A, Purali N, Senel S . Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). Eur J Pharm Sci. 2010; 41(3-4):531-45. DOI: 10.1016/j.ejps.2010.08.011. View

Vidal Bonifacio B, da Silva P, Dos Santos Ramos M, Negri K, Bauab T, Chorilli M . Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine. 2013; 9:1-15. PMC: 3862741. DOI: 10.2147/IJN.S52634. View

Ugwoke M, Agu R, Verbeke N, Kinget R . Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev. 2005; 57(11):1640-65. DOI: 10.1016/j.addr.2005.07.009. View

Gao B, Wang J, Wang D, Zhu Z, Qiao Z, Yang G . A novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorption. Int J Nanomedicine. 2013; 8:3927-35. PMC: 3798150. DOI: 10.2147/IJN.S48597. View

de Moura M, Aouada F, Mattoso L . Preparation of chitosan nanoparticles using methacrylic acid. J Colloid Interface Sci. 2008; 321(2):477-83. DOI: 10.1016/j.jcis.2008.02.006. View

Malhotra M, Lane C, Tomaro-Duchesneau C, Saha S, Prakash S . A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis. Int J Nanomedicine. 2011; 6:485-94. PMC: 3088072. DOI: 10.2147/IJN.S17190. View

Gerdts V, Mutwiri G, Richards J, van Drunen Littel-van den Hurk S, Potter A . Carrier molecules for use in veterinary vaccines. Vaccine. 2012; 31(4):596-602. DOI: 10.1016/j.vaccine.2012.11.067. View

10.

Cui Z, Mumper R . Chitosan-based nanoparticles for topical genetic immunization. J Control Release. 2001; 75(3):409-19. DOI: 10.1016/s0168-3659(01)00407-2. View

11.

Tretyakova I, Lukashevich I, Glass P, Wang E, Weaver S, Pushko P . Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Vaccine. 2013; 31(7):1019-25. PMC: 3556218. DOI: 10.1016/j.vaccine.2012.12.050. View

12.

Arifin M, Mel M, Karim M, Ideris A . Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor. J Biomed Biotechnol. 2010; 2010:586363. PMC: 2896699. DOI: 10.1155/2010/586363. View

13.

Tseng L, Chiou C, Deng M, Lin M, Pan R, Huang Y . Evaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunity. J Biomed Mater Res B Appl Biomater. 2009; 91(2):621-625. DOI: 10.1002/jbm.b.31437. View

14.

Rauw F, Gardin Y, Palya V, Anbari S, Gonze M, Lemaire S . The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol. 2009; 134(3-4):249-58. DOI: 10.1016/j.vetimm.2009.10.028. View

15.

Slutter B, Plapied L, Fievez V, Sande M, des Rieux A, Schneider Y . Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Control Release. 2009; 138(2):113-21. DOI: 10.1016/j.jconrel.2009.05.011. View

16.

Zhao K, Shi X, Zhao Y, Wei H, Sun Q, Huang T . Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine. 2011; 29(47):8549-56. DOI: 10.1016/j.vaccine.2011.09.029. View

17.

Abbas A, Donovan M, Salem A . Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery. J Pharm Sci. 2007; 97(7):2448-61. DOI: 10.1002/jps.21215. View

18.

Zhao K, Li W, Huang T, Luo X, Chen G, Zhang Y . Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles. PLoS One. 2014; 8(12):e82648. PMC: 3873271. DOI: 10.1371/journal.pone.0082648. View

19.

Zhao K, Zhang Y, Zhang X, Li W, Shi C, Guo C . Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Int J Nanomedicine. 2014; 9:389-402. PMC: 3890423. DOI: 10.2147/IJN.S54226. View

20.

Zhao K, Chen G, Shi X, Gao T, Li W, Zhao Y . Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles. PLoS One. 2013; 7(12):e53314. PMC: 3532065. DOI: 10.1371/journal.pone.0053314. View